I43.1 I35.0
Conditions
Interventions
Group 1: Establishment of a register about TAVR-Patients with suspected cardiac ATTR-Amyloidosis, observational study, data from clinical routine procedures
Sponsors
Uniklinik Köln, Kardiologie
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients at age of 65 years and older with myocardial hypertrophy (interventricular septum thickness of 12 mm and more) with are undergoing TAVR for aortic valve stenosis. Every patient must agress to the information and consent of the study.
Exclusion criteria
Exclusion criteria: Patients who do not agree to the information and consent of the study, patients who are currently in panel system and patients who do not meet the inclusion criteria can not be enrolled. Also patients who do not agree to undergo further diagnostics (if indicated) can not bei enrolled.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Establishment of a multicenter register for better understanding of cardiac transthretin amyloidosis in TAVR patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Development of a clinical algorithm for diagnosis of ATTR cardiomyopathy in TAVR patients which will be based on reliable prevalence estimates and the prospective evaluation of the discriminatory value of clinical characteristics. | — |
Countries
Germany
Contacts
Public ContactSvenja Ney
Uniklinik Köln, Kardiologie
Outcome results
None listed